1.1. Disparities in Accessing Healthcare Services
According to Whitehead and Dahlgren, echoing the World Health Organization constitution [
1], “equity in health implies that everyone could ideally attain their full health potential, and that no one should be disadvantaged from achieving this potential because of their social position or other socially determined circumstance”. Healthcare organizations operate on the assumption that they have a contractual obligation to the public, requiring them to address population-level inequities and shed light on them. Furthermore, these organizations are committed to addressing the methodological challenges associated with establishing the causal mechanisms, determinants, or correlations of these inequities. The aim is to identify factors within the control of the healthcare system that can be influenced. Should there be disparities in accessing healthcare services, the hosting organization bears the responsibility to rectify them. If healthcare service organizations wish to become effective for health interventions, organizations need to prioritize locally relevant strategies that are oriented to working with vulnerable groups [
2]. Consequently, the challenge lies in tracing these inequities back to their root causes or determinants and relating them to factors that fall within the organization’s purview.
Certain groups of patients considered vulnerable have been extensively examined, with considerable research focusing on achieving equitable access to healthcare services. Health inequality affects all Canadians, but for vulnerable populations, it has a much stronger impact on their health [
3]. Several studies, including [
4,
5], have demonstrated that vulnerable patients tend to have an overall lower quality of life and health. Additionally, access to care is one of the most significant challenges affecting the quality of life of vulnerable populations [
6]. The lack of proper access to healthcare can potentially lead to a reduced life span compared to the general population. Such population groups include individuals affected by, e.g., psychiatric issues such as schizophrenia [
7,
8]. Research has shown that individuals with schizophrenia have an exceptionally short life expectancy, averaging approximately 20 years below that of the general population [
8]. Moreover, high mortality is found in all age groups, with two-thirds of this excess mortality caused by natural deaths [
7,
8]. One of the factors that influence this reduction in life expectancy include the fact that common physical illness are diagnosed late and do not receive sufficient treatment, in spite of the fact that people with schizophrenia tend to live an unhealthy lifestyle with regards to diet, smoking, alcohol consumption, and lack of physical exercises [
8].
People with mental health and substance use (MHSU) [
9] and those suffering from homelessness [
9,
10] as well as physical mobility [
11] and neurocognitive disorders [
12] tend to have less access to healthcare services. Lack of access to proper services for serious/chronic mental health issues has also been shown to be one of the major challenges in treating those mental health and addictions issues that lead to homelessness and an excessive use of some services such as emergency departments [
10,
13]. Moreover, mobility limitations is especially true for older adults [
14,
15] and may be due to chronic conditions, including arthritis and chronic lung problems [
16,
17]. Access to physicians and sub-specialty care has also been shown to be more difficult for patients with mobility impairment [
18], hence compromising their quality of care delivery. Furthermore, despite the fact that neurocognitive disorders represent a growing major concern in the world, with a growing aging population, treatment and management of neurocognitively impaired patients remains suboptimal due to inadequate treatment and poor quality of care, increasing the risks of adverse outcome [
12].
Various stigmatization are also known to negatively impact access to healthcare services [
16,
19,
20]. There are various types of stigmas, including health condition-related stigma and non-health-related stigma. Health condition-related stigma affects people living with a specific disease or health condition, including leprosy, epilepsy, mental health disorders, cancer, HIV, and obesity/overweight [
21]. Non-health-related stigma include socio-economic status, age, gender, race, and sexual orientation [
22]. A stigma can be a barrier to care for patients seeking support to maintain a healthy quality of life, seeking disease prevention service, or treatment for acute or chronic healthcare conditions [
23]. In health facilities, the manifestation of stigma may result in subtle forms of deprivation such as longer waits for services or being referred to junior providers [
23,
24]. It may also manifest in an outright denial of services, physical or verbal abuse, or provision of sub-standard care [
23]. As a result, stigma within healthcare may undermine access to diagnosis and treatment and result in poor or unsuccessful health outcomes [
23,
25,
26,
27].
The above-cited studies capture the typical reality of cohorts of patients accessing specific services. The challenge is the fact that these studies do not provide a nuanced perspective based on the local reality across the full care continuum. It is common to look at differences in access to certain services, such as how often a cohort of patients accesses the emergency department. It is also common to look at differential access to a specific service within a medical specialty such as cardiovascular. However, a view of patient access from a cross-continuum, including secondary and tertiary services, is what is lacking from these studies. If the goal is to address disparities in access to services for vulnerable patients that may be affected by a diverse array of needs, there is no need to restrict one’s view to a limited number of services, but one should rather provide visibility to all services across the continuum of care. Using local data to capture the local reality, the advocated approach provides the opportunity to (1) determine whether the disparity shows up consistently across areas or is specific to some services and not others and (2) facilitate the determination of whether the disparity in access lies with the patients’ capacity to advocate for services and/or initiate/maintain access to services or with the service system structure or a combination of the two factors. This provides a potential for a tangible solution to address the disparity.
Moreover, if we are concerned with disparities in access, there is an immediate problem that need to be addressed. Addressing disproportionately high rates of access to a given service, e.g., large numbers of emergency department visits for persons in a specific demographic or contending with a specific underlying condition, is methodologically straightforward. However, when addressing disparities in access, our efforts frequently involve compiling aggregate counts for events that have yet to occur. To do this, we need some sort of reference standard or expected value, enabling us to interpret measured rates effectively and transform disparities into inequities. The problem is that for many cohorts and for many services, such standards may not exist, or they may be imprecise and therefore poorly positioned as a basis for determining when rates of service access fall “out of range”. For example, how many cardiovascular-related investigative procedures should be performed for persons with schizophrenia who are not yet displaying obvious signs/symptoms of cardiovascular illness? Such information may or may not be found in the literature. If we further partition that group into persons with schizophrenia and a comorbid substance use disorder vs. persons with schizophrenia without a comorbid substance use disorder, will the reference standard be readily available in the literature as well? Operating on the assumption that externally supplied reference standards are generally not going to be available for a method that must be general in scope, we may resort to cohort comparison design—using rates for other groups as a proxy for external reference standards.
Prior works [
28,
29,
30] have developed methodologies to extract patterns of service utilization (PSUs) from longitudinal electronic healthcare records to optimize healthcare services. Expanding on this by (1) using source data consisting of longitudinal transactional service encounter data provided by one of the health authorities in Canada and (2) relying on a cohort comparison design, this paper proposes a methodology that uses patients’ encounter data represented as a graph to analyze access to healthcare services for a set of patient cohorts with varied levels of vulnerabilities, as chosen by clinical subject-matter experts (SMEs). The goal is to corroborate previous findings and offer a more nuanced perspective on access inequities. Providing this type of analysis will help facilitate the identification of the factors that are within the control of the host organization to address the inequities. Moreover, the focus of the paper is methodological, and a host organization can apply the proposed methodology to any cohort of interest.
1.2. Objectives
This paper illustrates a method for locating cohort-specific disparities in health service access within large and sparse high-dimensional, full cross-continuum health service datasets that span hospital and community sectors for medical/surgical as well as mental health and/or substance use/addictions services. These disparities are important when they are not commensurate with need or risk, as they then become markers for inequities in health service access. Ethically, healthcare organizations are obligated to acknowledge and address these inequities by shedding light on them and identifying factors within their control. This study illustrates a specific instance of a broader methodology that utilizes a set of longitudinal health service encounter data to identify and quantify cohort-specific disparities in access to healthcare services.
Using a cross-continuum healthcare dataset from a regional health authority, the goal is to provide a more nuanced understanding of healthcare access disparity, focusing on a chosen set of patient cohorts with distinguishing levels of vulnerabilities. Also, the work does not assume that the identified disparities arise solely from clinical cohort-defining characteristics of persons, in which case disparities would be expected to show up consistently across the service area. In keeping with the working hypothesis that disparities are a joint function of features of persons and features of service system structures and functions, the study looks for disparities in both medical/surgical and MHSU service areas.
To summarize, the work presented in the paper is organized around three overarching substantive questions:
Are there disparities in service access or patterns of service utilization (PSUs) that are associated with cohort membership? For the work in this paper, cohorts are distinguishable on the basis of expected differential capacity to initiate access to anything other than low-barrier access services, e.g., emergency departments, and remain connected to services over time. The term “vulnerable” is used in this paper to refer to that capacity.
Do identified disparities in access show up consistently across service areas?
To what extent can we use PSUs to identify healthcare access inequities and provide a more refined approach in assessing the cause of the inequity?
To address the above questions, from a methodological perspective, the following approaches are used:
Cohort comparison: Patients in the chosen cohorts of interest are users of medical/surgical and/or MHSU services. However, one of the cohorts is made of patients that are considered more vulnerable than the other. Using PSUs, the cohort of more vulnerable patients will be compared to a cohort of patients with less severe vulnerability in terms of access to various healthcare services. When measuring access disparities for the above cohorts, both empirical and statistical approaches will be used, and the results will be compared;
Consultation with SMEs will be conducted to review the results and to answer the questions that were raised earlier regarding determinants of access.